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The respiratory system is endowed with a number of structural and functional barriers that 
protect it against harmful and innocuous material from taking advantage of its vast surface 
area to gain access into the organism. These barriers include; 1) the surfactant system 2) a 
highly efficient mucociliary escalator system 3) a population of highly phagocytic 
macrophages and 4) an epithelium endowed with tight junctions. However, despite these 
barriers, pulmonary immune responses are easily generated by introduction of antigens into 
the airways. These responses are thought to be mediated via dendritic cells, which are 
located in the basal aspect of the epithelium,and the most potent antigen presenting cells in 
the lung. Although there is substantial information on the nature of interaction between 
dendritic cell and particles from in vitro experiments, there is little information on how the 
particles breach the barrier to reach the immunocompetent cells. An understanding of how 
these particles pass the epithelial barrier to reach the immunocompetent cells is important in 
the development of mucosal vaccines. Insights into how this may happen are discussed. 




The surface epithelium of the respiratory 
tract is the most extensive surface that 
interfaces directly between man and his 
environment. In an average human 
weighing about 74 Kg, it may comprise up 
to 143 m2 (Gehr et al., 1978) in surface 
area. This surface is exposed to a large 
load of particulate matter that is 
dependent on the level of environmental 
pollution, inhalability of the pollutant and 
the breathing habit of the individual 
(Stahlhofen et al., 1994; Roth et al., 
1997). It has been estimated that the 
human airways may be exposed to as 
much as 7 Kg of pollutants per year 
(Phalen 1984) although this may vary 
depending on the amount of particulate 
matter suspended in the inhaled air. To 
counter the danger posed by these 
particles, the lung is endowed with several 
structural and functional barriers that 
constitute its innate immunity against 
harmful and innocuous particles from 
reaching the rest of the body organs. 
These barriers include the following 1) the 
surfactant system (Schürch et al., 1990; 
Gehr et al., 1990), 2) a highly efficient 
mucociliary escalator system (Kilburn 
1968), 3) a population of highly 
phagocytic macrophages (Geiser et al., 
1990; Crystal 1991), and 4) a continuum 
of epithelium endowed with tight junctions 
(Breeze and Wheeldon 1977; Barry 1987). 
Nevertheless, numerous epidemiological 
studies have shown that particulate air 
pollution is associated with increased 
morbidity and mortality (Brunekreef 1997; 
Pope et al.,2009 Pope et al., 2014). 
Further, immune response related 
diseases are common in the lung, which 
suggests that breach of this barrier 
occurs. One factor that has been said to 
predispose to breaching of the barrier is 
particle-overload (Oberdöster et al., 
1994). The phenomena of particle 
overload suggest that the lung barrier 
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system can only handle up to a given 
maximum particulate volume beyond 
which the particles will inevitably get into 
contact with the epithelium and become 
interstitialised (Marrow 1988; Oberdöster 
et al., 1994) where they may reach the 
dendritic cells. Furthermore, twenty years 
ago, Gehr and Schürch(1992) reported 
that upon inhalation, small particles are 
forcefully displaced by the surfactant 
lining film towards the airway epithelium 
forming a depression on the epithelial 
cells. The displacement enables the 
particles to interact with airway 
macrophages and perhaps dendritic cells 
(Gehr et al., 1996) thereby determining 
their fate. 
 
 Dendritic cells are recognized as the main 
antigen presenting cells in the lung (Holt 
et al., 1990; Nicod 1997) and the nature 
of how they acquire antigens is a 
prerequisite in understanding the 
consequences of particle-lung interaction. 
Of particular importance is how the 
antigens can reach DC, which are the 
most competent antigen presenting cells 
in the lung (Holt et al., 1990; Nicod, 
1997). The location of DCon the basal 
surface of the epithelium and lack of cells 
such as M cells in the airway epithelium 
suggests that there may be active and yet 
unresolved mechanisms of antigen 
delivery to the DC in the airways.  Are the 
antigens phagocytosed and delivered 
byairway macrophages? Do they 
penetrate through the airway epithelial 
cells, or do the antigens pass through the 
tight junction. Is there a possibility that 
the DC collect the particles by pushing 
cytoplasmic processes beyond the tight 
junctions into the airway lumen (Rescigno 
et al., 2001; Vermaelen et al, 2001; 
Takano et al., 2005)? How does this 
antigen delivery change during epithelial 
injury and repair, which is a common 
feature of inflammatory airway disease, 
like asthma (Gaurav and Agrawal 2013)? 
These questions need urgent answers. 
 
Dendritic cells 
Dendritic cells (DC) are professional 
antigen presenting cells that play a critical 
role in generating primary and secondary 
immune responses against specific 
antigens (Steinman, 1991). Priming of 
naive T lymphocytes, proliferation and 
functional differentiation of antigen-
specific T cells as well as development of 
antigen specific T cell tolerance depends 
on an appropriate T cell - dendritic cell 
interaction (Banchereau et al., 2000). The 
high capacity of DC to stimulate T 
lymphocytes is attributed to (1) a high DC 
level of adhesion molecules that may 
favour T cell receptor engagement 
(Steinman, 1991), (2) high expression 
levels of co-stimulatory molecules on the 
DC that facilitate T cell activation 
(Katayama et al., 1997; Quaratino et al., 
2000) as well as (3) expression of high 
level of major histocompatibility complex 
molecules (Inaba et al., 1994; Cella et al., 
1997).  
 
DC were first isolated from murine spleen 
suspension and defined on morphological 
grounds (Steinman and Cohn, 1973). They 
were shown to display a distinctive 
dendritic morphology (Figure1). 
Subsequently, the DC were defined by 
functional criteria, notably the lack of 
endocytic activity invitro and in vivo, the 
inability to retain antigens or immune 
complexes on their surface and a low 
labelling index in vitro (1.5–2.5%) 
following administration of [3H] thymidine 
(Steinman and Cohn, 1974). 
Nonphagocytic DC were later isolated from 
rat peripheral lymph (Pugh et al., 1983) 
and human lung parenchyma (Nicod et al., 
1987). The lack of endocytic activity was a 
paradox since antigen uptake and 
processing is expected to precede antigen 
presentation (Steinman and Swanson 
1995). 
 
Life cycle of dendritic cells. 
The origin and ontogeny of DC have been 
reviewed in detail (Hart, 1997; Granucci 
and Zanoni 2009). Evidence of bone 
marrow origin of dendritic cells was 




demonstrated from irradiation 
reconstitution experiments following bone 
marrow transplantation (Katz et al., 
1979)(Figure 2). Furthermore, 
perturbation of the respiratory tract 
mucosa is knownto induce mobilization of 
DC in the respiratory epithelium. 
Inhalation of viruses, bacterial and soluble 
protein antigens result in recruitment of 
DC into the respiratory mucosa followed 
by DC migration to the lymph node (Mc 
Williamset al., 1996). Subsequently, the 
migratory immature dendriticcells undergo 
maturation and become professional 
antigen presenting cells (Banchereau and 
Steinman, 1998). Maturation changes DC 
in many ways that explain their potent 
antigen presenting capacity to naive T 
cells.These changes include: (1) a high 
expression of T lymphocytes co-
stimulatory molecules such as B7-2 (Inaba 
et al., 1994), (2) production of IL-12 
(Cella et al., 1996), (3) redistribution of 
MHC class II molecules from nonlysosomal 
vesicles to the cell surface (Pierra et al., 
1997, Turley et al., 2000), (4) an 
upregulation of CCR7 that guide migration 
of DC into the T cell areas (Forster et al., 
1999), (5) expression of DC survival 
molecule, TRANCE-R (Wong et al., 1997), 
(6) a high expression of adhesion 
molecules such as ICAM-1, ICAM-3 and 
LFA-3 (Banchereau and Steinman, 1998) 
and (7) downregulation of dextran uptake 
(Cochand et al., 1999). In addition, 
human DC havebeen shown to reduce 
their phagocytic capacity on maturation 
(Kiama et al., 2001).  
 
Dendritic cells in the epithelial tissue. 
An interdigitating network of DC has been 
described in the intestinal and respiratory 
tract of rat and humans (Holt et al., 1988; 
Pavli et al., 1993). Studies from P. Holt’s 
laboratory (Schon-Hegrad et al., 1991; 
Holt et al., 1994) and other laboratories 
(Nicod et al., 1987; Gong et al., 1992) 
have identified two main populations of 
DC in the lung that differ in location, 
phenotype and turnover. One population 
which exhibits a high turnover (2 to 3 
days), and a more immature phenotype 
residing in the conducting airways just 
below the epithelium (Sertl et al., 1986; 
Holt et al., 1988) and the second 
population, that is fairly sparse, exhibiting 
a more advanced stage of differentiation, 
a slower turnover (7 days) located in the 
alveolar septa (Holt et al., 1994).  
 
Densities of DC in the rat are highest in 
the upper airways (600-800/mm2) and 
decrease with progression down the 
respiratory tree, reaching 75/mm2 in the 
small airways of the peripheral lung 
(Schon-Hegrad et al., 1991). The airway 
mucosal DC population is capable of up 
regulation in response to both acute and 
chronic inflammation (McWilliamset al., 
1994). Targeting these cell population 
with vaccines presents high potential of 
inducing strong mucosal and systemic 
immunity. However, a good understanding 
of how the potential vectors reach the DC 
is a prerequisite in achieving desirable 
immunogenic responses. 
 
Function of Dendritic cells. 
DC are professional antigen presenting 
cells (Steinman, 1991 van Spriel and de 
Jong 2014). They phagocytose,  
processand present immunogenic epitopes 
in the context of MHC class I and/or class 
II molecules for recognition by T 
lymphocytes (Hart, 1997; Alberts 1998). 
Besides presenting the antigens, the DC 
are endowed with an array of 
costimulatory molecules whose interaction 
with complementary molecules on the T 
lymphocytes ensures optimal T cell 
activation (Banchereau and Steinman, 
1998). In addition to their antigen 
presenting function, DC serve a sentinel 
function. DC survey epithelial surfaces 
such as the skin, respiratory tract and 
gastrointestinal tract for agents that may 
present a threat to health. The sentinel 
position of the DC stands out after a 
challenge of the respiratory mucosa with 
Moraxella catarrhalis. Inhalation of M. 
catarrhalis organisms is accompanied by 
an amplification of active DC surveillance 
in the airways that results in an increase 
in the traffic of the DC between the airway 




epithelium and the regional lymph nodes 
(McWilliamset al., 1994). Besides 
stimulating T lymphocytes, DC are now 
known to have effects on B cell growth 
and immunoglobulin secretion 
(Banchereau et al., 2000). DC activate and 
expand T-helper cells, which in turn 
induce B cell growth and antibody 
production (Briere et al., 1999). Human 
DC have been reported to skew isotope 
switching of CD40-activated naive B cells 
in presence of IL-10 and TGF-  towards 
IgA secreting cells (Fayette et al., 1997). 
Immunoglobulin A is the major class of 
immunoglobulin present in the mucosa of 
the healthy respiratory tract and is 
thought to be the most important 
immunoglobulin for lung defence (Lamm, 
1997). This suggests that DC are in 
control of mucosal immunity, since DC 
located in the airway epithelia could 
directly influence the isotype switch of B 
cells towards IgA. Other functions of the 
DC include induction of central and 
peripheral tolerance (Banchereau and 
Steinman, 1998), control of Th1/Th2 
directed immune responses (Rissoan et 
al., 1999) and linking of innate and 
adaptive immunity via production of 
interferon alpha (Palucka and Banchereau, 
1999). 
Our studies and other reports have 
demonstrated that DC are efficiently 
phagocytic for a variety of particles such 
as, 1) polystyrene particles (Kiama et al, 
2001; 2) puff ball spores,3) biodegradable 
microspheres made of poly(lactid-co-
glycolid) acid (PLGA) (Walter et al., 2001), 
and 4) Salmonella typhimurium (Kiama et 
al., 2006; Dreher et al., 2001). The uptake 
of Salmonella and PLGA particles by DC is 
important because of their potential use in 
drug delivery and as vectors in delivery of 
DNA vaccines. This is because, Salmonella 
not only invade DC very efficiently but 
also induces the expression of 
costimulatory signals for T cell (Dreher et 
al. 2001 ) and hence can serve as a 
carrier of the vaccine. Salmonella was also 
found to induce formation of microvesicles 
after infection of DC (Kiama et al., 2006). 
The significance of these microvesicles 
(Szakal et al., 1988) in amplification of 
immunity on salmonella based vaccine 
remains to be explored (Obregon et al., 
2006). Whereas much is known on the 
interaction of particles with DC and with 
alveolar macrophages there is no 
sufficient data on how the antigens reach 
the DC (Vermaelen and Pauwels, 2005; 
Takano et al., 2005).  
 
Surfactant barrier 
The primary role of pulmonary surfactant 
is to reduce surface tension forces in the 
lung and to stabilize pulmonary alveoli 
(Schürch et al., 1976). However, it is now 
generally well recognized that surfactant 
may also serve the role of a barrier to 
inhaled antigens reaching the epithelium 
(Pison et al., 1994) and the dendritic cells. 
It does this through several mechanisms 
that include: 1) enhancing mucociliary 
clearance (De Sanctis et al., 1994), 2) 
improving phagocytosis of particles by 
alveolar macrophages (Pison et al., 1994), 
and 3) displacing small particles to the 
vicinity of macrophages and epithelial cells 
(Gehr et al., 1990; Schürch et al., 1990; 
Geiser et al., 2000). In view of the 
concomitant observation of surfactant 
deficiencies and poor airways clearance in 
lung diseases such as cystic fibrosis and 
asthma (Griese et al., 1997; Meyer et al., 
2000), unravelling the role which 
surfactant may play as a barrier of 
particles to reach the epithelium and 
subsequently the dendritic cells would 
provide useful information on how to treat 
such diseases. Furthermore, emerging 
evidence indicate that surfactant proteins 
A and D modulates dendritic cell function 
and helper T cell polarization (Nayak et al, 




The efficiency of the mucociliary barrier 
depends on among other factors, the 
morphological integrity of the cilia 
structure and mucus components (Werner 
et al., 1996). Impairment of the 
mucociliary barrier, which is common in 
diseases such as cystic fibrosis and 




asthma, predisposes to bacterial 
colonization of the airways (Werner et al., 
1996). Although impaired clearance is 
known to result in prolonged retention of 
deposited particles, its contribution to 
antigens gaining access to dendritic cells 
through the epithelium has not been 
determined. Delayed clearance of particles 
deposited in the airways would predispose 
to a breach of airway epithelial barrier 
highlighting the risk of particles gaining 




Figure 2: A schematic illustration of the life cycle of Dendritic cell. The Dc precursors 
migrate from the bone marrow to the epithelium where they differentiate to immature 




dendritic cells. The immature dendritic cells take up antigen and migrate to the regional 
lymph node in the process maturing to the professional antigen presenting cells. 
 
Figure 1: An Electron micrograph of a dendritic cell displaying the long dendritic processes 





Airway macrophages are highly phagocytic 
and are rapidly recruited to the locations 
where particles have been deposited 
(Geiser et al., 1994). Macrophage 
overloading though, may interfere with 
the ability of these cells to phagocytise 
(Oberdoster et al., 1994). The 
phenomenon of particle-overload assumes 
that macrophages can only engulf up to a 
given maximum volume of particles 
(Morrow 1988; Oberdöster et al., 1994). 
Morrow (1988) suggested that alveolar 
macrophage functions begin to be 
impaired when on average 6 % of its 
volume is filled by phagocytosed particles. 
The capacity of pulmonary DC to serve as 
antigen presenting cells for heat killed 
Listeria after in vivo challenge is observed 
only when the dose of heat-killed Listeria 
exceeded 109 organisms per rat (MacLean 
et al., 1996). Moreover, elimination by 
alveolar macrophages in vivo is associated 
with increased pulmonary immune 
response to intra-tracheal administered 
heat-killed Listeria (Kradinet al., 1999) 
implying that macrophages serve a 
protective role. This suggests that particle 
overload plays a role in the breaching of 
the epithelial barrier. 
 
Epithelial barrier 
A continuous layer of epithelial cells joined 
by tight junctions (Breeze and Wheeldon 
1977) lines the pulmonary airways. The 
tight junctions completely prevent the 
diffusion of macromolecules through the 
intercellular spaces across the epithelium 
(Balda and Matter, 1998). Transport of the 
particles to the DC cells presupposes their 
passage across the epithelium, although 
the route they take has not been 
determined. Vermaelen and colleagues 
(2001) reported that fluorescein 
isothiocyanate (FITC)- conjugated 
macromolecules are transported to the 
tracheal lymph nodes by airway DC after 
an intratracheal instillation. However, the 
mechanism in which the macromolecules 
passed through the epithelium to reach 
the DC was not provided. Takano and 
colleagues (Takano et al., 2005) showed 
that dendritic cells easily access antigens 
beyond epithelial tight junctions in human 
nasal mucosa, but of allergic rhinitis only. 




Another in vitro model using mouse 
tracheal epithelial cells and mouse bone 
marrow dendritic cells showed impaired 
migration of metalloproteinase-9-deficient 
dendritic cells through tracheal epithelial 
tight junctions (Ichiyasu et al., 2004). 
Furthermore, there is evidence that 
dendritic cells play an important role in 
the pathogenesis of allergic asthma, and 
there is an increased number of dendritic 
cells in the airway mucosa of patients with 
chronic obstructive pulmonary disease 
(Vermaelen and Pauwels, 2005). 
In conclusion, once particles have evaded 
thesurfactant, mucociliary, macrophages 
and the epithelial barrier they come into 
contact with the professional antigen 
presenting cells, the dendritic cells. One or 
several mechanisms may be involved in 
breaching each barrier which could 
determine the outcome of the dendritic 
cell-particle interaction. Thus, concerted 
studies ought to be carried out to unravel 
how each barrier is breached perhaps 
identify whether there is a critical barrier 
and thus answer the questions. Are all the 
barriers equally important or is there one 
that is more redundant?. Or even the 
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